Your session is about to expire
← Back to Search
Device
MKTP with dermabrasion/collagen dressing for Vitiligo (MKTP Trial)
N/A
Waitlist Available
Led By Iltefat H Hamzavi, MD
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Depigmented patches of skin
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this study is to: 1. Compare two different techniques in the melanocyte keratinocyte transplant procedure: Use of carbon dioxide laser versus use of dermabrasion 2. Compare two different dressings in the melanocyte keratinocyte transplant procedure: vaseline impregnated gauze versus collagen dressing
Eligible Conditions
- Vitiligo
- White scars
- Leukoderma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Vitiligo Assessment Scoring Index (VASI)
Secondary study objectives
Pain Severity Scale
Time to De-Epithelialization
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Active Control
Group I: MKTP with dermabrasion/collagen dressingActive Control3 Interventions
Each subject will have a depigmented patch of skin treated with MKTP using dermabrasion for de-epithelialization and a collagen dressing for the wound dressing.
Group II: MKTP with CO2 laser/vaseline gauzeActive Control3 Interventions
Each subject will have a depigmented patch of skin treated with MKTP using the carbon dioxide laser for de-epithelialization and vaseline impregnated gauze as the wound dressing.
Group III: MKTP with dermabrasion/vaseline gauzeActive Control3 Interventions
Each subject will have a depigmented patch of skin treated with MKTP using dermabrasion for de-epithelialization and vaseline impregnated gauze as a wound dressing.
Group IV: MKTP with CO2 Laser/Collagen DressingActive Control3 Interventions
Each Subject will have a depigmented patch of skin treated with MKTP using the carbon dioxide laser for de-epithelialization and a collagen dressing for the wound dressing.
Find a Location
Who is running the clinical trial?
Henry Ford Health SystemLead Sponsor
311 Previous Clinical Trials
2,176,346 Total Patients Enrolled
7 Trials studying Vitiligo
74 Patients Enrolled for Vitiligo
Iltefat H Hamzavi, MDPrincipal InvestigatorHenry Ford Dermatology
6 Previous Clinical Trials
113 Total Patients Enrolled
2 Trials studying Vitiligo
40 Patients Enrolled for Vitiligo
Share this study with friends
Copy Link
Messenger